Clinical Trials, Centers Would Be First In Line For Money Added To Budget, Broder Tells Congress
In Brief: Michael Grever Named DCT Deputy Director; MSK’s Burton Lee New White House Physician
Conte To Introduce Bill To Stem Loss Of NIH “Superstars”
ACCC Joins ONS In Opposing RCT Caregiver Category
Dinner To Raise Funds For NIH Children’s Inn
NCI Advisory Group, Other Cancer Meetings


Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - USPSTF convenes first meeting in over a year
- Cancer Grand Challenges awards $10M to research team aiming to develop AI “co-scientists”
AI agents would narrow the “incredibly large combinatorial universe of cancer questions” - Philadelphia cancer center directors talk city-wide collaboration
“A bench-to-bedside-to-block model” - The next revolution in cancer care may be manufactured at the bedside
As personalized mRNA cancer vaccines move toward clinical reality, the challenge will be to make them broadly available









